The pharmaceutical industry is under increasing pressure, with rising costs of research and development (R&D) eroding profit margins. The entire…
Agios Pharmaceuticals presented mature data from its pivotal Phase III study ClarIDHy in cholangiocarcinoma for its IDH1 inhibitor Tibsovo (ivosidenib)…
The global economic growth in 2020 has been eclipsed since the COVID-19 pandemic outbreak causing fears of looming unemployment and recession in a number of…
Zelboraf is indicated for the treatment of metastatic melanoma and Erdheim-Chester disease. The Signant Health Partner Program aims to enable CROs to better serve sponsors…
MabSpace Biosciences has merged with HJB to create a fully-integrated biotherapeutics company named Transcenta Holding. Transcenta will have more than…
Antengene Corporation has raised $120m in a series B funding round led by Boyu Capital and FountainVest. The funding round…
DelSiTech has signed an agreement with Innovare for the development of long-acting human immunodeficiency virus (HIV) therapeutics. Innovare will make upfront…
10x Genomics has acquired Spatial Transcriptomics to enter the field of spatial genomics. The acquisition will enable 10x Genomics to gain…
On 17 November 2020, Novartis registered a Phase III psoriatic arthritis (PsA) clinical trial of its IL-17 inhibitor Cosentyx (secukinumab)…
As the world continues to fight the COVID-19 pandemic while still trying to find its footing with the economy, the…
When it comes to clinical trial submission, one of the most significant standards is the Analysis Data Model (ADaM), as…
Small animal optical imaging provides oncology researchers with the ability to perform non-invasive longitudinal monitoring of disease progression, detection of…
GEMTESA® (vibegron) is the first new oral medication indicated for the treatment of overactive bladder (OAB) with signs of urge…
OpenClinica is pleased to announce that it will be included in public television series In Depth, exhibiting its clinical trials…
